U.S. Personal Products Stock News

This article examines whether Pentair, trading at around US$86.49, is offering fair value or a mispriced opportunity by breaking down what the current share price might be implying about the company. Over the past month the stock has recorded a 15.2% decline and an 18.0% decline year to date, while the 3 year and 5 year returns of 69.8% and 48.2% provide a longer term contrast to the recent 2.6% 7 day move and 2.8% 1 year decline. Recent market attention on Pentair has been shaped by ongoing...

Earnings, guidance, and buybacks reshape the Macy's (M) story Macy's (M) is back in focus after issuing 2026 earnings guidance, reporting fourth quarter and full year results, and updating investors on the completion of a multi year share repurchase program. See our latest analysis for Macy's. Macy's recent 2026 guidance, Q4 earnings, and completion of the buyback program have all landed against a mixed backdrop, with a 7 day share price return of 4.56% alongside a 30 day share price return...

Tesla (NasdaqGS:TSLA) and SpaceX are launching Terafab, an AI chip factory complex in Austin, Texas, to supply chips for vehicles, humanoid robots, and AI space data centers. The Terafab project links automotive and aerospace chip needs within a single vertically controlled manufacturing hub. Tesla is planning a US$2.9b purchase of solar manufacturing equipment from Chinese suppliers to build out 100 gigawatts of U.S. solar production capacity by 2028. These projects represent...

Why a European patent ruling has IPG Photonics (IPGP) back in focus IPG Photonics (IPGP) is under renewed scrutiny after the Unified Patent Court in Düsseldorf found that certain uses and designs of its adjustable mode beam lasers infringe a Trumpf patent, affecting products in Germany, France and Italy. The ruling currently applies to AMB lasers that represent less than 1% of company sales. However, potential remedies such as an injunction, recall or damages, along with IPG’s decision to...

If you are wondering whether Morningstar's current share price truly reflects its underlying value, this breakdown will help you put the numbers into context. The stock recently closed at US$179.07, with a 2.0% decline over the last 7 days, a 12.3% gain over 30 days, and returns of a 14.9% decline year to date and a 40.6% decline over the last year. These moves sit against a backdrop of ongoing attention on Morningstar as a data and research provider, with investors weighing how its role in...

Earlier in March 2026, Hims & Hers Health announced that Kathryn Beiser, a veteran of Discover, Kaiser Permanente, Eli Lilly, and Edelman, had joined as Chief Communications Officer to lead its internal and external communications. Her appointment comes just after the company repaired its relationship with Novo Nordisk over weight-loss drugs, highlighting a sharpened focus on branding and stakeholder messaging around its broader telehealth ambitions. We’ll now explore how the renewed Novo...

Why Linde’s recent performance is drawing attention Linde (LIN), a global industrial gas company, is back on many investors’ radars after a solid past 3 months, with the share price posting a total return above 14%. That move follows a longer run of positive multi year total returns and sits alongside annual revenue of US$33.99b and net income of US$6.90b. This combination is prompting closer scrutiny of what is currently priced in. See our latest analysis for Linde. Over the past year,...

Wondering if MDU Resources Group at around US$19.65 is offering value right now, or if the recent run puts it on the expensive side. The stock has pulled back about 4.7% over the past week and 2.9% over the past month, although the 1 year return sits at 18.7% and the 3 and 5 year returns are 91.5% and 89.5% respectively. Recent coverage has focused on MDU Resources Group as a regulated utility and infrastructure business. Investors are paying attention to how its mix of operations and...

EMCOR Group (NYSE:EME) has been added to the FTSE All-World Index. This index inclusion is effective with the latest rebalance of FTSE Russell global benchmarks. The move may draw additional attention from institutional and index tracking investors. For EMCOR Group, trading at $724.93, inclusion in a global benchmark index comes after a very large 5 year return and a 76.0% return over the past year. Even with a 10.8% decline over the past 30 days and a 0.2% decline over the past week, the...

If you are asking whether Sunoco shares are still reasonably priced after a strong run, the answer depends on how you look at value and which metrics you trust most. With the stock at US$64.73, recent returns have been mixed, including a 0.4% decline over the last 7 days, a 3.5% gain over 30 days, 22.8% year to date, 21.4% over 1 year, 85.4% over 3 years, and 184.2% over 5 years. Investor attention has been shaped by ongoing coverage of Sunoco's role in the US energy sector, including...

Why Syndax Pharmaceuticals (SNDX) Is Drawing Investor Attention Now Syndax Pharmaceuticals (SNDX) has been catching investor interest after recent trading, with the stock last closing at US$24.23 and recent returns over the month and past 3 months standing out in the biotech space. See our latest analysis for Syndax Pharmaceuticals. For context, Syndax Pharmaceuticals has a 30 day share price return of 23.06% and a year to date share price return of 13.76%, while the 1 year total shareholder...

Investors may be wondering if Astera Labs at around US$116 per share still offers value after a big run, or if they might be late to the story. The stock is up 63.2% over the last year, although the 7 day, 30 day and year to date returns of 3.5%, 10.5% and 35.4% declines show that enthusiasm has cooled recently. Recent coverage has focused on Astera Labs as a key player in semiconductor infrastructure and AI related hardware. This helps explain why the share price has attracted attention...

Earlier in March 2026, Ambarella outlined its expanding Edge AI strategy at the Cantor Fitzgerald Global Technology and Industrial Growth Conference, revealing that Edge AI now contributes 80% of revenue and grew 50% over the prior year while also launching indirect sales channels and a semi-custom chip program targeting a future two-nanometer design. This shift toward a higher-mix Edge AI portfolio, coupled with plans for advanced semi-custom chips, marks a meaningful evolution in how...

Why International Seaways is on investors’ radar International Seaways (INSW) has drawn fresh attention after recent trading, with the share price around $67.75 and total return over the past 3 months and year highlighting how tanker exposure has recently played out for holders. See our latest analysis for International Seaways. The recent 1 day share price return of a 5.3% decline contrasts with a 41.5% 3 month share price gain and a very large 5 year total shareholder return. This suggests...

Franklin Resources, Inc. was recently removed from the FTSE All-World Index (USD), a move that may trigger portfolio rebalancing among index-tracking funds and institutional investors. This index exclusion puts a spotlight on how much of Franklin Resources’ investor base relies on benchmark-linked capital versus active, discretionary ownership. We’ll now examine how Franklin Resources’ removal from the FTSE All-World Index could reshape its investment narrative and future capital...

Aon plc recently announced past leadership changes effective March 2026, including appointing Anne Corona as CEO of North America, elevating Lori Goltermann to Vice Chair, and naming Farheen Dam as CEO of Enterprise Clients and Chief Client Officer, alongside several client-focused innovation initiatives spanning healthcare risk, delegated authority technology, and stablecoin premium settlements. Together, these leadership moves and client partnerships highlight how Aon is applying its risk,...

In March 2026, Darden Restaurants reported third-quarter sales of US$3,345.3 million, up from US$3,158.0 million a year earlier, while net income eased to US$306.8 million from US$323.4 million and earnings per share edged lower. Alongside this, the company raised its fiscal 2026 outlook with expected total sales growth of about 9.5% and same-restaurant sales growth of about 4.5%, signaling confidence in its brands’ ability to grow traffic and spend despite mixed profit trends. We’ll now...

Firefly Aerospace (FLY) is back on investors radar after reporting Q4 and full year 2025 results, issuing new 2026 revenue guidance of US$420 million to US$450 million, and completing the successful Alpha Flight 7 launch. See our latest analysis for Firefly Aerospace. Firefly Aerospace’s 16.22% 1 month share price return sits against an 18.81% 3 month share price decline and a modestly lower year to date share price. This suggests recent earnings, guidance and launch milestones are starting...

Mattel (MAT) is back in focus after unveiling a Barbie x CCM hockey collection with CCM Hockey, a product tie-up that extends the Barbie brand into performance sports gear while highlighting inclusivity and self expression. See our latest analysis for Mattel. Despite the renewed attention around Barbie and CCM Hockey, Mattel's share price return has weakened. A 30 day share price return of a 14.82% decline and a 1 year total shareholder return of a 25.10% decline suggest that momentum has...

Recent performance snapshot for Philip Morris International (PM) Philip Morris International (PM) has drawn investor attention after recent share price weakness, with a 7 day return of about a 7% decline and a one month return of roughly an 11% decline from its last close of $163.11. See our latest analysis for Philip Morris International. The recent 7-day and 30-day share price declines sit against a steadier picture, with a modestly positive year-to-date share price return and a stronger...

Why fresh concerns around Post Holdings (POST) are back in focus Recent bearish commentary on Post Holdings (POST) has zeroed in on declining U.S. cereal consumption, tougher competition from alternative breakfast options, and expectations of margin pressure and slower organic growth. See our latest analysis for Post Holdings. Post Holdings' recent share price weakness, including a 9.4% 1 month share price return and a 13.25% 1 year total shareholder return, suggests sentiment has cooled even...

Biogen (BIIB) is back in focus after Eisai and the company shared new real-world data at AD/PD 2026, showing that many patients remain on Alzheimer’s drug lecanemab beyond the initial 18-month treatment period. See our latest analysis for Biogen. Despite the positive lecanemab and pipeline headlines in recent weeks, Biogen’s share price has eased, with a 1-month share price return of a 5.5% decline and a 7-day return of a 1% decline, while the 1-year total shareholder return of 28.15%...

Why Brinker International (EAT) is Catching Investor Attention Now Brinker International (EAT) is back on many watchlists after recent share price weakness, with negative returns over the past week, month, past 3 months and year prompting fresh questions about valuation and earnings power. See our latest analysis for Brinker International. Despite the recent share price weakness, with the latest close at US$143.40 and a year to date share price decline of 5.36%, the three year total...

Mineralys Therapeutics, Inc. recently reported that its 2025 fourth-quarter net loss narrowed to US$32.23 million from US$48.95 million a year earlier, while the U.S. FDA accepted its New Drug Application for lorundrostat in adult hypertension with a PDUFA action date of December 22, 2026. The combination of reduced annual net loss to US$154.65 million and FDA review acceptance for lorundrostat marks a shift toward a more advanced, late-stage profile for Mineralys as it moves closer to a...